Tumor-induced osteomalacia: a clinical case report
Tatiana A. Grebennikova,
Diliara Sh. Umiarova,
Konstantin Y. Slashchuk,
Mikhail V. Degtyarev,
Svetlana S. Rodionova,
Pavel O. Rumyantsev,
Zhanna E. Belaya 
Abstract
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome usually caused by small-sized tumors. Tumors secrete fibroblast growth factor 23 (FGF23), which has a phosphaturic effect. The clinical signs of TIO are non-specific, and include fatigue, bone pain and muscle weakness, which makes timely diagnosis of the disease difficult and treatment is often delayed.
Well-timed diagnosis is essential and combined with complete tumor resection it leads to complete relief of symptoms and good postoperative prognosis. In cases of undetected tumors, medical treatment with phosphate supplements and active vitamin D medications is usually successful, however, treatment is associated with numerous complications and side effects can be burdensome for the patients. Due to the risk of recurrence or metastasis, patients with TIO require long-term management and follow-up.
In this article, we present a clinical case of successful diagnosis and treatment of TIO in a young patient with type 1 diabetes mellitus.
About the Authors
Tatiana A. GrebennikovaEndocrinology Research Centre
Russian Federation
MD, PhD
Diliara Sh. Umiarova
Endocrinology Research Centre
Russian Federation
MD, resident
Konstantin Y. Slashchuk
Endocrinology Research Centre
Russian Federation
MD
Mikhail V. Degtyarev
Endocrinology Research Centre
Russian Federation
MD
Svetlana S. Rodionova
National Research Center for Preventive Medicine
Russian Federation
MD, PhD, professor
Pavel O. Rumyantsev
Endocrinology Research Centre
Russian Federation
MD, PhD
Zhanna E. Belaya
Endocrinology Research Centre
Russian Federation
MD, PhD, Professor
References
1. Bhatt AA, Mathews SS, Kumari A, Paul TV. Tumour-induced osteomalacia. Hong Kong Medical Journal. 2014;20(4):350.e351-350.e352. doi: https://doi.org/10.12809/hkmj133981
2. Попова И.Ю., Гребенникова Т.А., Тюльпаков А.Н., и др. Редкие генетические заболевания костной ткани: клиническое наблюдение семьи с несовершенным остеогенезом и фосфопенической формой остеомаляции. // Остеопороз и остеопатии. — 2018. — Т. 21. — №1. — С. 28-33. [Popova IYu, Grebennikova TA, Tiulpakov AN, et al. Rare genetic diseases of the bone tissue: The case of a family with osteogenesis imperfecta and X-linked hypophosphataemia. Osteoporosis and bone diseases. 2018;21(1):28-33. (In Russ.)]. doi: 10.14341/osteo9756
3. Manara M, Sinigaglia L. “Slow and steady wins the race”: the importance of perseverance in the management of oncogenic osteomalacia. Endocrine. 2016;57(1):1-2. doi: https://doi.org/10.1007/s12020-016-1187-z
4. Tiefenbach M, Scheel M, Maier A, et al. Osteomalazie – Klinik, Diagnostik und Therapie. Z. Rheumatol. 2018;77(8):703-718. doi: https://doi.org/10.1007/s00393-018-0510-x
5. Boland JM, Tebben PJ, Folpe AL. Phosphaturic mesenchymal tumors: what an endocrinologist should know. J. Endocrinol. Invest. 2018;41(10):1173-1184. doi: https://doi.org/10.1007/s40618-018-0849-5
6. Yin Z, Du J, Yu F, Xia W. Tumor-induced osteomalacia. Osteoporosis and Sarcopenia. 2018;4(4):119-127. doi: https://doi.org/10.1016/j.afos.2018.12.001
7. Chong WH, Molinolo AA, Chen CC, Collins MT. Tumor-induced osteomalacia. Endocr. Relat. Cancer. 2011;18(3):R53-R77. doi: https://doi.org/10.1530/erc-11-0006
8. Colangelo L, Cipriani C, Pepe J, et al. A Challenging Case of Tumor-Induced Osteomalacia: Pathophysiological and Clinical Implications. Calcif. Tissue Int. 2018;103(4):465-468. doi: https://doi.org/10.1007/s00223-018-0429-x
9. Minisola S, Peacock M, Fukumoto S, et al. Tumour-induced osteomalacia. Nature Reviews Disease Primers. 2017;3(1). doi: https://doi.org/10.1038/nrdp.2017.44
10. Lamb YN. Burosumab: First Global Approval. Drugs. 2018;78(6):707-714. doi: https://doi.org/10.1007/s40265-018-0905-7
Supplementary files
|
|
1. Fig. 1. Planar scintigraphy with 99mTc-Tectrotide patient G. | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(75KB)
|
Indexing metadata ▾ | |
|
|
2. Fig. 2. Results of SPECT-CT of patient G. There is a focus of radiopharmaceutical accumulation in the region of the left knee joint | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(23KB)
|
Indexing metadata ▾ | |
Review
For citations:
Grebennikova T.A., Umiarova D.Sh., Slashchuk K.Y., Degtyarev M.V., Rodionova S.S., Rumyantsev P.O., Belaya Zh.E. Tumor-induced osteomalacia: a clinical case report. Osteoporosis and Bone Diseases. 2018;21(4):24-28. (In Russ.)
Views:
2979
Email this article 
